RCM
CRXT

Radcliffe Capital Management’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Radcliffe Capital Management’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-225,000
Closed -$2.27M – 988
2021
Q2 		$2.27M Hold
225,000
– – 0.07% 443
2021
Q1 		$2.27M Buy
+225,000
New +$2.27M 0.09% 391